April 22, 2022 Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis read more
April 4, 2022 Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients read more
Scientific American February 8, 2021 Detecting Alzheimer’s Gets Easier with a Simple Blood Test read more
March 22, 2021 Ultrasensitive quantification of plasma biomarkers is shaping the future of care for Alzheimer’s disease read more
August 14, 2020 Quanterix Simoa® Technology Powered Nearly 60 Posters And Presentations At Alzheimer’s Association International Conference (AAIC) 2020 read more